Navigation Links
TGen-Scottsdale Healthcare clinical trial finds new class of cancer drugs safe and effective
Date:4/9/2013

SCOTTSDALE, Ariz. April 9, 2013 The safety and preliminary efficacy of a new class of tumor fighting drugs were reported today by Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials and the Translational Genomics Research Institute (TGen).

Early results from the phase I, first in-human study of an RNA interface (RNAi) drug were announced during the American Association for Cancer Research (AACR) Annual Meeting 2013, April 6-10, in Washington, D.C. The drug, TKM-080301 (also known as TKM-PLK1) is being developed by Tekmira Pharmaceuticals Corporation.

The study was conducted at Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare, a partnership with TGen. It found that the RNAi drug acts by silencing the PLK1 gene involved in tumor growth and can be safely administered in humans. Most patients tolerated the drug well; some showed therapeutic benefit.

"RNAi therapies are a unique approach to cancer treatment as they have the potential to 'turn off' the genes' coding for proteins involved in cancer cell division," said Dr. Ramesh K. Ramanathan, Medical Director of Virginia G. Piper Cancer Center Clinical Trials at Scottsdale Healthcare and deputy director of the Clinical Translational Research Division of TGen. "Using a lipid nanoparticle, the RNAi drug can be delivered to a cancer cell to block the expression of specific proteins involved in tumor growth."

TKM-080301 targets a specific gene called polo-like kinase 1 (PLK1), which codes for a protein involved in tumor cell growth. Prior research has shown that high levels of PLK1 are present in many types of cancer, including many of the more aggressive forms.

"Our preclinical results have shown that by decreasing PLK1 levels in cancer cells, we can stop tumor growth and kill the cancer cells," Dr. Ramanathan said.

He and his colleagues have been enrolling patients with advanced solid tumors or lymphoma into the ongo
'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
2. Coral Calcium Company Announces New Offer Amidst Supreme Court Healthcare Decisions
3. Healthcare researchers recognized at SingHealth Duke-NUS Scientific Congress 2012
4. Daily disinfection of isolation rooms reduces contamination of healthcare workers hands
5. Health inequalities could be reduced by more effective healthcare, says new study
6. Healthcare ethics consultants share lessons learned
7. Kessler Foundation stroke expert receives $145,000 grant from Healthcare Foundation of New Jersey
8. Social environmental factors affect rehospitalization risk in home healthcare patients
9. TGen, Scottsdale Healthcare lead worldwide study of new drug for patients with pancreatic cancer
10. CWRU dental and nursing students collaborate for one-stop healthcare
11. University Hospitals & Philips Healthcare to showcase imaging technology at Cleveland Medical Mart
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... SC (PRWEB) May 26, 2015 On May ... by Oceans 6 salesman and distributor Dwayne Windfall. At the ... food supply company that has some unique characteristics with it, ... the food business?” Windfall replies saying, “I was reading the ... ad that said they were looking for a person with ...
(Date:5/26/2015)... Pasadena porcelain veneers dentist, Dr. ... cosmetic treatments. Cosmetic dentistry is becoming increasingly popular in ... are committed to providing you with the highest level ... and a smile of a lifetime … We work ... to change your life,” explains Dr. Martirosyan’s team. “Giving ...
(Date:5/26/2015)... USA (PRWEB) May 26, 2015 Based ... site, AnyTranscription has undertaken a comprehensive upgrade of its ... in user experience. To thank users for their feedback ... this five minute trial transcription service promotion. ... from May 26 to June 9 this year. During ...
(Date:5/26/2015)... 2015 Adenna, Inc ., worldwide ... excited to announce the launch of Enov8 ... made of polyethylene (PE) and approved by the U.S. ... , The Enov8 glove might look like ... mixing salads but our proprietary formula and production technology ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Learning ZoneXpress ... line, Nutrition Education Cards . These cards have ... engaging photography and simple, easy-to-read text, these new educational ... . They offer practical nutrition tips and suggestions to ... titles available are: , + MyPlate: Eat for a ...
Breaking Medicine News(10 mins):Health News:My Positive Perspective Broadcasts Episode with Oceans 6 to Discuss Their Role in Helping the Community 2Health News:Pasadena Porcelain Veneers Expert, Marine Martirosyan DDS, is Now Offering Complimentary Dental Cleaning with Cosmetic Treatments 2Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 2Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 3Health News:Enov8® Exam Glove by Adenna® Approved by U.S. FDA 2Health News:Learning ZoneXpress Introduces New Educational Resource for WIC, SNAP-Ed, and EFNEP 2
... 6 Medical professionals,have long sought new treatments for ... A new therapy, based on,hypnosis, is currently being tested ... of surgery., Your Cancer Today interviews Guy H. ... Montgomery,s study looked at two groups of patients,facing surgery ...
... women surveyed about their beliefs surrounding miscarriage and birth defects ... negatively affect her baby. , One in four of ... could hurt her unborn child, and one in five believed ... Despite those beliefs, relatively few of the women surveyed blamed ...
... WHITE PLAINS, N.Y., DECEMBER 5, 2007 The preterm birth ... show a continued increase, underscoring the urgent need for a ... The more we learn about the terrible consequences of an ... to understand what causes preterm birth and how it can ...
... 6, 2007 -- A new study recently published in the ... novel benefit in slenderizing thighs. , The Brazilian researchers studied ... 7 percent caffeine solution. The women used the cream twice ... their subjects measurements at the end of the study, the ...
... Taking ,Unacceptable Risk, With Patient, FORT WORTH, Texas, ... million to the family of a 75-year-old Fort Worth ... his symptoms., Jurors deliberated about six hours over ... 236th District Court of Judge Thomas W. Lowe III.,The ...
... $24 Million Worth of,Prescription Drugs Through Rogue Internet ... Lifestyle, Including Seven,Convertibles, Four Stretch Limousines & Maybach ... National Health,Care Anti-Fraud Association (NHCAA) today is presenting ... and Treasury the 2007,Fraud "Investigation of the Year" ...
Cached Medicine News:Health News:Reducing Pain via Hypnosis, This Week on Your Cancer Today (TM) 2Health News:Miscarriage myths persist despite prevalence of medical information 2Health News:Miscarriage myths persist despite prevalence of medical information 3Health News:Miscarriage myths persist despite prevalence of medical information 4Health News:Jury Awards $5.25 Million Malpractice Verdict Against Fort Worth Doctor 2Health News:NHCAA Presents 2007 Fraud 'Investigation of the Year' Award to U.S. Departments of Justice, HHS, and Treasury for Convicting Internet Pharmacy 'Drug Kingpin' 2Health News:NHCAA Presents 2007 Fraud 'Investigation of the Year' Award to U.S. Departments of Justice, HHS, and Treasury for Convicting Internet Pharmacy 'Drug Kingpin' 3
(Date:5/26/2015)...  Accuray Incorporated (Nasdaq: ARAY ), announced today ... the Jefferies 2015 Healthcare Conference in New ... 2:30pm ET.   A live webcast of ... page of the Company,s website at http://www.accuray.com/investors . ... one hour after the conclusion of the live presentation ...
(Date:5/26/2015)... , May 26, 2015 Connected health ... diverse devices and workflows, aiding diagnosis, monitoring and ... infrastructure to be efficient, stakeholders must first ensure ... Logo - http://photos.prnewswire.com/prnh/20150526/218313LOGO ... Healthcare and Medical Device Connectivity and Interoperability, finds ...
(Date:5/26/2015)... Columbia , May 26, 2015  InMed ... today that it has filed a provisional patent ... Office ("USPTO") relating to the treatment of Epidermolysis ... cannabinoid compounds developed by InMed. ... Scientific Officer, commented, "We are excited to file ...
Breaking Medicine Technology:Interoperability among Connected Medical Devices Can Potentially Transform Healthcare 2Interoperability among Connected Medical Devices Can Potentially Transform Healthcare 3InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 2InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 3
... One of the biggest challenges faced by healthcare ... preference items (PPI), such as orthopedic implants, cardiac stents, pacemakers ... most expensive items that hospitals buy. GHX will present strategies ... 2010 Annual Conference & Exhibition, to be held Aug. ...
... Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first in ... and live audio webcast at 8:30am EDT on August ... corporate highlights. , , ... participate in the conference call, please dial 800-860-2442 (domestic) or 412-858-4600 (international). ...
Cached Medicine Technology:GHX to Present Strategies to Optimize Procurement, Especially of Physician Preference Items, at Annual AHRMM Conference 2GHX to Present Strategies to Optimize Procurement, Especially of Physician Preference Items, at Annual AHRMM Conference 3BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2010 Financial Results on August 6, 2010 2BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2010 Financial Results on August 6, 2010 3
Inquire...
Sealing Mat for 96-well, 2.0ml, Deep Well, Square Available Sterile...
Silicone Compression Mat, Bulk...
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
Medicine Products: